|
Mirataz
|
20 mg/g
|
EU/2/19/247/001
|
Dechra Regulatory B.V., Nīderlande
|
QN06AX11
|
cats
|
|
Medicinal product information
| Pharmaceutical form: |
ointment
|
| International name (active substance): |
Mirtazapine (as hemihydrate)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Klifovet AG , Vācija
|
| Date of authorisation/renewal: |
10-Dec-2019
|
| Marketing authorisation valid until: |
09-Dec-2024
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/247/001 |
20 mg/g |
1 |
Alumīnija tūbiņa, 5 g |
-
|
|